Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 9 |
GO:0110165 | cellular anatomical entity | 1 | 9 |
Related structures:
AlphaFold database: A0A3Q8I7X8
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 128 | 130 | PF00675 | 0.618 |
CLV_NRD_NRD_1 | 24 | 26 | PF00675 | 0.566 |
CLV_NRD_NRD_1 | 8 | 10 | PF00675 | 0.491 |
CLV_PCSK_KEX2_1 | 128 | 130 | PF00082 | 0.605 |
CLV_PCSK_KEX2_1 | 24 | 26 | PF00082 | 0.393 |
CLV_PCSK_KEX2_1 | 8 | 10 | PF00082 | 0.483 |
CLV_PCSK_SKI1_1 | 49 | 53 | PF00082 | 0.425 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.637 |
DOC_CKS1_1 | 94 | 99 | PF01111 | 0.421 |
DOC_CYCLIN_yCln2_LP_2 | 52 | 58 | PF00134 | 0.587 |
DOC_PP4_FxxP_1 | 56 | 59 | PF00568 | 0.592 |
DOC_PP4_FxxP_1 | 82 | 85 | PF00568 | 0.470 |
DOC_USP7_MATH_1 | 122 | 126 | PF00917 | 0.400 |
DOC_WW_Pin1_4 | 105 | 110 | PF00397 | 0.399 |
DOC_WW_Pin1_4 | 93 | 98 | PF00397 | 0.415 |
LIG_14-3-3_CanoR_1 | 24 | 28 | PF00244 | 0.627 |
LIG_14-3-3_CanoR_1 | 3 | 7 | PF00244 | 0.693 |
LIG_14-3-3_CanoR_1 | 66 | 70 | PF00244 | 0.360 |
LIG_14-3-3_CanoR_1 | 9 | 15 | PF00244 | 0.663 |
LIG_BRCT_BRCA1_1 | 67 | 71 | PF00533 | 0.360 |
LIG_deltaCOP1_diTrp_1 | 61 | 64 | PF00928 | 0.442 |
LIG_LIR_Apic_2 | 117 | 122 | PF02991 | 0.405 |
LIG_LIR_Apic_2 | 79 | 85 | PF02991 | 0.283 |
LIG_LIR_Nem_3 | 61 | 65 | PF02991 | 0.442 |
LIG_LIR_Nem_3 | 68 | 74 | PF02991 | 0.279 |
LIG_Pex14_2 | 56 | 60 | PF04695 | 0.590 |
LIG_SH2_CRK | 20 | 24 | PF00017 | 0.645 |
LIG_SH2_CRK | 78 | 82 | PF00017 | 0.395 |
LIG_SH2_SRC | 115 | 118 | PF00017 | 0.434 |
LIG_SH2_STAP1 | 78 | 82 | PF00017 | 0.279 |
LIG_SH2_STAT5 | 46 | 49 | PF00017 | 0.640 |
LIG_SH3_3 | 91 | 97 | PF00018 | 0.408 |
LIG_TYR_ITIM | 76 | 81 | PF00017 | 0.410 |
MOD_CK1_1 | 4 | 10 | PF00069 | 0.680 |
MOD_CK2_1 | 10 | 16 | PF00069 | 0.646 |
MOD_Cter_Amidation | 126 | 129 | PF01082 | 0.703 |
MOD_GlcNHglycan | 124 | 127 | PF01048 | 0.632 |
MOD_GlcNHglycan | 9 | 12 | PF01048 | 0.447 |
MOD_GSK3_1 | 34 | 41 | PF00069 | 0.651 |
MOD_LATS_1 | 32 | 38 | PF00433 | 0.633 |
MOD_N-GLC_1 | 122 | 127 | PF02516 | 0.603 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.626 |
MOD_NEK2_1 | 45 | 50 | PF00069 | 0.612 |
MOD_NEK2_1 | 64 | 69 | PF00069 | 0.445 |
MOD_PKA_2 | 2 | 8 | PF00069 | 0.658 |
MOD_PKA_2 | 23 | 29 | PF00069 | 0.761 |
MOD_PKA_2 | 65 | 71 | PF00069 | 0.354 |
MOD_ProDKin_1 | 105 | 111 | PF00069 | 0.396 |
MOD_ProDKin_1 | 93 | 99 | PF00069 | 0.418 |
TRG_ENDOCYTIC_2 | 78 | 81 | PF00928 | 0.297 |
TRG_ER_diArg_1 | 128 | 130 | PF00400 | 0.418 |
TRG_ER_diArg_1 | 23 | 25 | PF00400 | 0.731 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IJC2 | Leptomonas seymouri | 92% | 100% |
A0A0S4JUP5 | Bodo saltans | 65% | 100% |
A0A1X0NV45 | Trypanosomatidae | 79% | 100% |
A4H6G8 | Leishmania braziliensis | 98% | 100% |
A4HUW7 | Leishmania infantum | 100% | 100% |
D0A7J2 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 72% | 100% |
E9ANJ6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 98% | 100% |
Q4QH30 | Leishmania major | 99% | 100% |
V5DT78 | Trypanosoma cruzi | 73% | 100% |